DOCTEUR ABBOUD
ActiveDOCTEUR ABBOUD has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €118k and a net result of €-51k. Equity is shrinking by ~6.7% per year across the filed fiscal years. Its solvency ranks better than 27% of 2315 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
67
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability53▼-45
Solvency55▲+7
Growth32▼-26
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 1.74 against 1.08 in 2024; short-term debt: 40.6% and cash: 15.1% of total assets), but 70.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
29.8%
Return on assets
-12.9%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-08-2026, 23 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
23 d late
2024
on the day
2023
on the day
2022
10 d late
2021
on the day
2020
44 d late
2019
on the day
← before the deadline
after the deadline →
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-51k
2024 · €174k
2019: €24k
2020: €29k
2021: €9k
2022: €-10k
2023: €-207k
2024: €174k
2019 → 2025
Working capital
€118k▲ 242%
2024 · €34k
2019: €166k
2020: €151k
2021: €137k
2022: €-5k
2023: €-242k
2024: €34k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€211k-€202k▼ 4.5%€-6k€169k€118k▼ 30.2%
Operating result€21k-€-4k€-204k▼ 4,579%€177k€-40k
Net result€9k-€-10k€-207k▼ 2,074%€174k€-51k
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €40k after €177k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €395k
Fixed assets
€117k▼ 54.4%
Current assets
€278k▼ 42.4%
Equity and liabilities €395k
Equity
€118k▼ 30.2%
Debt
€277k▼ 51.4%
The debt ratio falls from 77.2% to 70.2%. Equity and debt are lower.
Key figures and ratios
EBITDA
€98k▼
2024 · €290k
Cash flow
€88k▼
2024 · €286k
Solvency
29.8%▲
2024 · 22.8%
Current ratio
1.74▲
2024 · 1.08
Quick ratio
1.53▲
2024 · 1.00
Debt / equity
2.36▼
2024 · 3.39
ROE
-43.3%▼
2024 · 103.3%
ROA
-12.9%▼
2024 · 23.6%
Interest coverage
8.71▼
2024 · 51.64
Debt
€277k▼
2024 · €571k
Debt ≤ 1 year
€160k▼
2024 · €449k
Debt > 1 year
€117k▲
2024 · €112k
Income taxes
€2k▲
2024 · €2k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€739k€395k▼
Fixed assets21/28€256k€117k▼
Tangible fixed assets22/27€243k€104k▼
Plant, machinery and equipment23€53k€18k▼
Furniture and vehicles24€165k€68k▼
Other tangible fixed assets26€25k€18k▼
Financial fixed assets28€13k€13k=
Current assets29/58€483k€278k▼
Stocks and contracts in progress3€32k€33k▲
Stocks30/36€32k€33k▲
Amounts receivable within one year40/41€184k€113k▼
Trade receivables40€43k€46k▲
Other amounts receivable41€140k€66k▼
Current investments50/53-€70k
Cash at bank and in hand54/58€262k€60k▼
Deferred charges and accrued income490/1€5k€3k▼
Equity and liabilities
Total equity and liabilities10/49€739k€395k▼
Equity10/15€169k€118k▼
Contributions10/11€25k€25k=
Reserves13€40k€40k=
Non-distributable reserves130/1€3k€3k=
Reserves not available under the articles1311€3k€3k=
Tax-exempt reserves132€38k€38k=
Profit (loss) carried forward14€104k€53k▼
Amounts payable17/49€571k€277k▼
Amounts payable after more than one year17€112k€117k▲
Other amounts payable178/9€112k€117k▲
Amounts payable within one year42/48€449k€160k▼
Current portion of amounts payable after more than one year42€12k-
Trade debts44€148k€9k▼
Suppliers440/4€148k€9k▼
Taxes, remuneration and social security45€7k€20k▲
Taxes450/3€7k€20k▲
Other amounts payable47/48€282k€132k▼
Accrued charges and deferred income492/3€10k€472▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€112k€139k▲
Other operating charges640/8€3k€8k▲
Gross operating margin9900€292k€106k▼
Operating profit (loss)9901€177k€-40k▼
Financial income75/76B€4k€3k▼
Recurring financial income75€4k€3k▼
Financial charges65/66B€6k€11k▲
Recurring financial charges65€6k€11k▲
Profit (loss) for the period before taxes9903€176k€-49k▼
Income taxes67/77€2k€2k▲
Profit (loss) for the period9904€174k€-51k▼
Profit (loss) for the period to be appropriated9905€174k€-51k▼
Appropriation of the result
Profit (loss) to be appropriated9906€104k€53k▼
Profit (loss) brought forward from the previous period14P€-71k€104k▲
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
23-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 23 days late
2025
31-01
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
30-06
Financial
Back to profitnet €174k
Net result €174k after 2 loss-making years.
30-06
Financial
Liquidity doublescurrent ratio 1.08
Current ratio from 0.48 to 1.08; short-term debt falls from €465k to €449k.
30-06
Financial
Equity above €150kEq €169k
Equity rises from €-6k to €169k.
31-01
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
30-06
Financial
Weakest financial yearnet €-207k
Net result drops to €-207k, the lowest in the series; recovery starts the following year.
10-02
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 10 days late
2022
31-01
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
16-03
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 44 days late
2020
30-06
Financial
Equity above €200kEq €202k ▲2.6%
2 profitable years in a row build equity to €202k.
31-01
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
28-02
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 28 days late
2018
29-01
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
27-02
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 27 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Vorst · 2 establishment units since 2002
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Penelopelaan 231190 VorstGround area
2,190 m²
Building footprint
1,249 m²
Volume, LiDAR
21,362 m³
2 parcels, Brussels · tallest building 26.5 m, ±7 floors. Linked by address, not a title deed.
2 establishment units
Penelopelaan 23, 1190 Vorst
since 20022.232.958.905
Wethoudersstraat 7, 1000 Brussel
since 20102.232.959.103
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21807G0131/00R000 | Brussels | 1,887 m² | 1 · 1,119 m² | 26.5 m · 7 fl. |
| 21383B0020/00X058 | Brussels | 303 m² | 1 · 130 m² | 15.7 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Gynécologie Philippe Simon
BE 0799.534.178
Ukkel · Eq €118k
MauCa
BE 0793.922.432
Tielt · Eq €118k
C FANDRE
BE 0746.932.662
Charleroi · Eq €118k
CARDIOLOGISCHE PRAKTIJK HERBOTS
BE 0634.853.320
Anderlecht · Eq €118k
DOCTEUR FERNANDE LOIS
BE 1017.244.344
Walhain · Eq €118k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 6,505 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded13-12-2002
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.